Tempest Therapeutics files updated corporate presentation; no specific new data disclosed in filing.

Tempest Therapeutics, Inc.

Company posted February 2026 investor presentation on its website.
Presentation title: 'Accelerating the Development of Advanced Therapies for Cancer Patients'.
No financial or clinical trial results were included in the 8-K filing.
Investors should refer to the full presentation on the company's website for details.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.